Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05873855 · ClinicalTrials.gov registry record · NA

Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru

A NA study of HIV Infections and HIV, sponsored by Florida International University.

Completed
Registry status
NA
Development phase
148
Enrollment target
1
Study location

NCT05873855: Completed NA study of HIV Infections and HIV, sponsored by Florida International University.

NCT05873855 is a NA study of HIV Infections and HIV that has completed, run by Florida International University. The registered enrollment target is 148 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05873855, a NA study of HIV Infections and HIV, has completed, sponsored by Florida International University.

COMPLETED
Registry status
NA
Development phase
148 participants
Enrollment target
1
Study location

Study Summary

This digital couples-based HIV/STI prevention intervention project will determine preliminary efficacy to improve uptake of evidence-based strategies and a tailored prevention plan among cisgender male couples who are in a relationship (defined as greater than 3 months or more).

Primary Outcome

Participants will be asked if they created a detailed risk-reduction plan that contains evidence-based strategies with their partner at all time points, using a dichotomous measure containing yes/no responses. Changes in number of individuals and couples who create a detailed risk reduction plan from baseline to 3-months, 3-months to 6-months, and baseline to 6-months.

Interventions

  • BEHAVIORAL Para ti, para mi, para nosotros (P3)
  • BEHAVIORAL Waitlist Control Para ti, para mi, para nosotros (P3)

Study Locations (1)

Florida

  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2022-12-27
Est. Completion 2025-06-30
Phase NA
Florida International University

89 total trials

What the finished NCT05873855 record still lists

NCT05873855 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (67% lower).

The record links to 6 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Para ti, para mi, para nosotros (P3) is the first listed.

NCT05873855 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05873855 about?

NCT05873855 is a clinical study titled "Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru". This digital couples-based HIV/STI prevention intervention project will determine preliminary efficacy to improve uptake of evidence-based strategies and a tailored prevention plan among cisgender male couples who are in a relationship (defined as greater than 3 months or more).

What is the current status of trial NCT05873855?

This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2022-12-27. Estimated completion is 2025-06-30.

What conditions does trial NCT05873855 study?

This clinical trial studies the following conditions: HIV Infections, HIV, Sexually Transmitted Diseases, Sexual Behavior, Risk Reduction.

What interventions are being tested in trial NCT05873855?

The interventions under investigation include: Para ti, para mi, para nosotros (P3) (BEHAVIORAL), Waitlist Control Para ti, para mi, para nosotros (P3) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05873855?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05873855 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05873855's enrollment target sits among peer trials

148 216th of 542 higher than 327 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00739362 · 148 participants · Phase 2

    Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT03858231 · 148 participants · Phase 4

    Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05873855, the US trial registry maintained by the National Library of Medicine. NCT05873855 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.